Lamivudine prevents reactivation of hepatitis B and reduces mortality in immunosuppressed patients: systematic review and meta‐analysis
@article{Katz2008LamivudinePR, title={Lamivudine prevents reactivation of hepatitis B and reduces mortality in immunosuppressed patients: systematic review and meta‐analysis}, author={L. Katz and A. Fraser and A. Gafter‐Gvili and L. Leibovici and R. Tur-Kaspa}, journal={Journal of Viral Hepatitis}, year={2008}, volume={15} }
Summary. To assess the effects of prophylactic lamivudine on reactivation and mortality following immunosuppressive therapy in hepatitis B surface antigen (HBsAg)‐positive patients, we performed a meta‐analysis. Systematic review and meta‐analysis of randomized and nonrandomized prospective controlled trials and retrospective comparative case series were identified through The Cochrane Hepato‐Biliary Group Controlled Trials Register, The Cochrane Central Register of Controlled Trials, MEDLINE… CONTINUE READING
Topics from this paper
133 Citations
Prophylactic lamivudine to improve the outcome of HBsAg-positive lymphoma patients during chemotherapy: a systematic review and meta-analysis.
- Medicine
- Clinics and research in hepatology and gastroenterology
- 2015
- 17
Meta-analysis of prophylactic entecavir or lamivudine against hepatitis B virus reactivation.
- Medicine
- Annals of hepatology
- 2016
- 5
Meta-analysis of prophylactic entecavir or lamivudine against hepatitis B virus reactivation.
- Medicine
- Annals of hepatology
- 2016
- 11
- PDF
Comparison of entecavir and lamivudine in preventing hepatitis B reactivation in lymphoma patients during chemotherapy
- Medicine
- Journal of viral hepatitis
- 2011
- 85
Hepatitis B virus management to prevent reactivation after chemotherapy: a review
- Medicine
- Supportive Care in Cancer
- 2012
- 27
A study of hepatitis B virus reactivation associated with rituximab therapy in real-world clinical practice: a single-center experience
- Medicine
- Clinical and molecular hepatology
- 2013
- 25
- PDF
Nucleos(t)ide analogues for preventing HBV reactivation in immunosuppressed patients with hematological malignancies: a network meta-analysis
- Medicine
- Expert review of anti-infective therapy
- 2017
- 10
Chemoprevention of Patients with Hepatitis B Receiving Chemotherapy or Bone Marrow Transplant
- Medicine
- 2010
- 1
- Highly Influenced
Entecavir is an optional agent to prevent hepatitis B virus (HBV) reactivation: a review of 16 patients.
- Medicine
- European journal of internal medicine
- 2010
- 32
References
SHOWING 1-10 OF 83 REFERENCES
Lamivudine for the prevention of hepatitis B virus reactivation in hepatitis B s-antigen seropositive cancer patients undergoing cytotoxic chemotherapy.
- Medicine
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- 2004
- 239
Primary prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HbsAg carriers with lymphoid malignancies treated with chemotherapy
- Medicine
- British journal of haematology
- 2001
- 173
Early is superior to deferred preemptive lamivudine therapy for hepatitis B patients undergoing chemotherapy.
- Medicine
- Gastroenterology
- 2003
- 418
A randomized controlled study of preemptive lamivudine in patients receiving transarterial chemo‐lipiodolization
- Medicine
- Hepatology
- 2006
- 169
- PDF
Extended lamivudine therapy against hepatitis B virus infection in hematopoietic stem cell transplant recipients.
- Medicine
- Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
- 2006
- 51
Lamivudine in the treatment of hepatitis B virus reactivation during cytotoxic chemotherapy
- Medicine
- Journal of medical virology
- 1999
- 114
Steroid‐free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV‐carriers with lymphoma
- Medicine
- Hepatology
- 2003
- 254
- PDF
Preemptive use of lamivudine reduces hepatitis B exacerbation after allogeneic hematopoietic cell transplantation
- Medicine
- Hepatology
- 2002
- 182
Lamivudine prophylaxis for prevention of chemotherapy‐induced hepatitis B virus reactivation in hepatitis B virus carriers with malignancies
- Medicine
- Journal of viral hepatitis
- 2004
- 86